Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: ...

Peethaambaran Kunnathoor, Chennai Tuesday, June 24, 2025, 08:00 Hrs [IST] ...

PCI directs institutions to appoint nodal officer & student ambassador to improve coordination: Gireesh Babu, New Delhi ...

Our Bureau, Bengaluru Tuesday, June 24, 2025, 17:20 Hrs [IST] ...

Our Bureau, Mumbai Tuesday, June 24, 2025, 16:50 Hrs [IST] ...

Navamedic enters agreement to acquire the business of Norwegian-based dne pharma for up to NOK 225 million: Oslo Tuesday, June 24, 2025, 16:00 Hrs [IST] Navamedic ASA, a Nordic ph ...

Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...

EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...

Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer: Basel Tuesday, June 24, 2025, 10:00 Hrs [IST] Novartis announced the expiration of the wa ...

EMA committee recommends marketing approval of AVT06, Alvotech’s proposed biosimilar to Eylea: Reykjavik, Iceland Tuesday, June 24, 2025, 17:00 Hrs [IST] Alvotech, a global biot ...